Therapeutic innovations for type 2 diabetes: if Nature is the solution?
There are nearly 9 million eukaryotic and prokaryotic species on earth, living in a wide variety of conditions ranging from thermal fissures to cold arctic environments. Anticancer, antiviral, antifungal drugs and antibiotics, are still directly extracted from many species or reproduced with improve...
Main Authors: | , , , , , |
---|---|
Format: | Text |
Language: | English |
Published: |
Zenodo
2020
|
Subjects: | |
Online Access: | https://dx.doi.org/10.5281/zenodo.4401965 https://zenodo.org/record/4401965 |
id |
ftdatacite:10.5281/zenodo.4401965 |
---|---|
record_format |
openpolar |
spelling |
ftdatacite:10.5281/zenodo.4401965 2023-05-15T15:01:31+02:00 Therapeutic innovations for type 2 diabetes: if Nature is the solution? Kwapich, Maxime Abderrahmani, Amar Plaisance, Valérie Pawlowski, Valérie Szunerits, Sabine Rabah Boukherroub 2020 https://dx.doi.org/10.5281/zenodo.4401965 https://zenodo.org/record/4401965 en eng Zenodo https://dx.doi.org/10.5281/zenodo.4401966 Open Access Creative Commons Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/legalcode cc-by-4.0 info:eu-repo/semantics/openAccess CC-BY Diabetes; insulin secretors; insulin sensitizers; pancreatic beta cell Text Journal article article-journal ScholarlyArticle 2020 ftdatacite https://doi.org/10.5281/zenodo.4401965 https://doi.org/10.5281/zenodo.4401966 2021-11-05T12:55:41Z There are nearly 9 million eukaryotic and prokaryotic species on earth, living in a wide variety of conditions ranging from thermal fissures to cold arctic environments. Anticancer, antiviral, antifungal drugs and antibiotics, are still directly extracted from many species or reproduced with improvements by chemical synthesis as biomimetics. GLP-1 analogues and metformin, respectively derived from the saliva of a venomous lizard of the Helodermatidae family and from the medicinal plant Galega Officinalis, are currently used as therapeutic drugs of type 2 diabetes worldwide. Therefore, the knowledge of terrestrial plants, animal species such as amphibians and reptiles, and aquatic biodiversity such as sponges and algae, may pave the way for the discovery of new insulin-secretagogues and insulin-sensitizers. Text Arctic DataCite Metadata Store (German National Library of Science and Technology) Arctic |
institution |
Open Polar |
collection |
DataCite Metadata Store (German National Library of Science and Technology) |
op_collection_id |
ftdatacite |
language |
English |
topic |
Diabetes; insulin secretors; insulin sensitizers; pancreatic beta cell |
spellingShingle |
Diabetes; insulin secretors; insulin sensitizers; pancreatic beta cell Kwapich, Maxime Abderrahmani, Amar Plaisance, Valérie Pawlowski, Valérie Szunerits, Sabine Rabah Boukherroub Therapeutic innovations for type 2 diabetes: if Nature is the solution? |
topic_facet |
Diabetes; insulin secretors; insulin sensitizers; pancreatic beta cell |
description |
There are nearly 9 million eukaryotic and prokaryotic species on earth, living in a wide variety of conditions ranging from thermal fissures to cold arctic environments. Anticancer, antiviral, antifungal drugs and antibiotics, are still directly extracted from many species or reproduced with improvements by chemical synthesis as biomimetics. GLP-1 analogues and metformin, respectively derived from the saliva of a venomous lizard of the Helodermatidae family and from the medicinal plant Galega Officinalis, are currently used as therapeutic drugs of type 2 diabetes worldwide. Therefore, the knowledge of terrestrial plants, animal species such as amphibians and reptiles, and aquatic biodiversity such as sponges and algae, may pave the way for the discovery of new insulin-secretagogues and insulin-sensitizers. |
format |
Text |
author |
Kwapich, Maxime Abderrahmani, Amar Plaisance, Valérie Pawlowski, Valérie Szunerits, Sabine Rabah Boukherroub |
author_facet |
Kwapich, Maxime Abderrahmani, Amar Plaisance, Valérie Pawlowski, Valérie Szunerits, Sabine Rabah Boukherroub |
author_sort |
Kwapich, Maxime |
title |
Therapeutic innovations for type 2 diabetes: if Nature is the solution? |
title_short |
Therapeutic innovations for type 2 diabetes: if Nature is the solution? |
title_full |
Therapeutic innovations for type 2 diabetes: if Nature is the solution? |
title_fullStr |
Therapeutic innovations for type 2 diabetes: if Nature is the solution? |
title_full_unstemmed |
Therapeutic innovations for type 2 diabetes: if Nature is the solution? |
title_sort |
therapeutic innovations for type 2 diabetes: if nature is the solution? |
publisher |
Zenodo |
publishDate |
2020 |
url |
https://dx.doi.org/10.5281/zenodo.4401965 https://zenodo.org/record/4401965 |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_relation |
https://dx.doi.org/10.5281/zenodo.4401966 |
op_rights |
Open Access Creative Commons Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/legalcode cc-by-4.0 info:eu-repo/semantics/openAccess |
op_rightsnorm |
CC-BY |
op_doi |
https://doi.org/10.5281/zenodo.4401965 https://doi.org/10.5281/zenodo.4401966 |
_version_ |
1766333540346101760 |